In this article, we demonstrate that conolidine, a normal analgesic alkaloid Employed in classic Chinese medication, targets ACKR3, thereby offering more evidence of a correlation in between ACKR3 and suffering modulation and opening substitute therapeutic avenues to the remedy of Persistent agony.SubscribeSign up for our newslettersSee the latest